Pages that link to "Q40504189"
Jump to navigation
Jump to search
The following pages link to An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model (Q40504189):
Displaying 50 items.
- Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures (Q26700070) (← links)
- Dengue Fever: Causes, Complications, and Vaccine Strategies (Q26700082) (← links)
- Can non-human primates serve as models for investigating dengue disease pathogenesis? (Q26825708) (← links)
- Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 (Q27480996) (← links)
- Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo (Q27486404) (← links)
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus (Q27486406) (← links)
- A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells (Q27487992) (← links)
- Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys (Q27489620) (← links)
- Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses (Q28729951) (← links)
- A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses (Q28741828) (← links)
- Prospects for a dengue virus vaccine (Q29619608) (← links)
- Current progress in dengue vaccines (Q33408300) (← links)
- Evaluation of dengue virus strains for human challenge studies. (Q33412959) (← links)
- Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines. (Q33961878) (← links)
- Report of an NIAID workshop on dengue animal models (Q34058747) (← links)
- Utility, limitations, and future of non-human primates for dengue research and vaccine development (Q34238916) (← links)
- Dengue vaccines: recent developments, ongoing challenges and current candidates (Q34367194) (← links)
- The history and evolution of human dengue emergence (Q34903764) (← links)
- Dengue vaccines: strongly sought but not a reality just yet (Q35008771) (← links)
- Progress towards a dengue vaccine (Q35009119) (← links)
- The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2. (Q35236379) (← links)
- An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques (Q35272502) (← links)
- Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development (Q35491639) (← links)
- Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys (Q35548048) (← links)
- Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization (Q35828002) (← links)
- Complementary alternative medicine use among patients with dengue fever in the hospital setting: a cross-sectional study in Malaysia. (Q35908624) (← links)
- Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial (Q36026210) (← links)
- Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy (Q36450864) (← links)
- Liposomal vaccines--targeting the delivery of antigen (Q36602259) (← links)
- An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection (Q36667964) (← links)
- Potential of ancestral sylvatic dengue-2 viruses to re-emerge (Q36718596) (← links)
- A dengue DNA vaccine formulated with Vaxfectin® is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits (Q36849774) (← links)
- TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis (Q37120117) (← links)
- Tick-borne Encephalitis Vaccines (Q37127083) (← links)
- A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates (Q37336762) (← links)
- Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses (Q37350360) (← links)
- Domain III of the envelope protein as a dengue vaccine target (Q37682895) (← links)
- DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice. (Q37694852) (← links)
- Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice (Q37694855) (← links)
- Strategies for the plant‐based expression of dengue subunit vaccines (Q37812659) (← links)
- Immune Response to Dengue Virus and Prospects for a Vaccine (Q37827145) (← links)
- Next generation dengue vaccines: a review of candidates in preclinical development (Q37904025) (← links)
- Identifying protective dengue vaccines: guide to mastering an empirical process (Q38125045) (← links)
- Challenges in reducing dengue burden; diagnostics, control measures and vaccines (Q38140035) (← links)
- Developing a dengue vaccine: progress and future challenges (Q38201151) (← links)
- Recent progress in dengue vaccine development (Q38303232) (← links)
- Trials and tribulations on the path to developing a dengue vaccine (Q38540058) (← links)
- Next generation dengue vaccines: A review of the preclinical development pipeline (Q38596321) (← links)
- Preclinical and clinical development of a dengue recombinant subunit vaccine (Q38605198) (← links)
- The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice (Q38905825) (← links)